Cohort profile: Risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study (队列简介:中国糖尿病患者肿瘤发生风险的纵向研究(REACTION研究))

Objective To demonstrate whether abnormal glucose metabolism (diabetes and prediabetes) is associated with increased risk for cancer in the Chinese population and to identify factors that modify the risk of cancer among individuals with abnormal glucose metabolism. Methods Between 2011 and 2012, 259...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes Vol. 6; no. 2; pp. 147 - 157
Main Authors: Bi, Yufang, Lu, Jieli, Wang, Weiqing, Mu, Yiming, Zhao, Jiajun, Liu, Chao, Chen, Lulu, Shi, Lixin, Li, Qiang, Wan, Qin, Wu, Shengli, Yang, Tao, Yan, Li, Liu, Yan, Wang, Guixia, Luo, Zuojie, Tang, Xulei, Chen, Gang, Huo, Yanan, Gao, Zhengnan, Su, Qing, Ye, Zhen, Wang, Youming, Qin, Guijun, Deng, Huacong, Yu, Xuefeng, Shen, Feixia, Chen, Li, Zhao, Liebin, Zhang, Jie, Sun, Jichao, Dai, Meng, Xu, Min, Xu, Yu, Chen, Yuhong, Lai, Shenghan, Bloomgarden, Zachary T., Li, Donghui, Ning, Guang
Format: Journal Article
Language:English
Published: Australia Blackwell Publishing Ltd 01-03-2014
John Wiley & Sons, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To demonstrate whether abnormal glucose metabolism (diabetes and prediabetes) is associated with increased risk for cancer in the Chinese population and to identify factors that modify the risk of cancer among individuals with abnormal glucose metabolism. Methods Between 2011 and 2012, 259 657 community‐dwelling adults, aged 40 years and older, were recruited from 25 centers across mainland China to participant in the baseline survey of the REACTION study, with follow‐up investigations performed 3, 5, and 10 years later. Detailed questionnaires about lifestyles, physical and biochemical measurement, bio‐samples including serum, urine, and whole blood for DNA extraction were collected for all the participants. Results The mean ± standard deviation (SD) age of this cohort was 57 ± 10 years. And the prevalence of pre‐existing and newly diagnosed diabetes was 10.32% and 10.57%, respectively. A total of 4511 prevalent cancer cases (988 men and 3523 women) were identified, the prevalence was 1.79. Compared to those with normal glucose metabolism, men with diabetes had a significantly lower adjusted prevalence ratio (PR) of stomach cancer (PR: 0.38, 95% CI: 0.16–0.89), and women with diabetes had significantly higher adjusted PRs of cancer of all sites (PR: 1.36, 95% CI: 1.20–1.56), and cancer of the breast (PR: 1.56, 95% CI: 1.21–2.00), the endometrium (PR: 1.58, 95% CI: 1.16–2.15), and the thyroid (PR: 1.53, 95% CI: 1.03–2.27). Conclusion The multi‐center REACTION study has captured a broad range of data on physical, psychological and metabolic function as well as health status, biochemical and lifestyle information in 259 657 adults from the general population across the China. 摘要 背景 评估在中国人群中糖代谢异常(糖尿病及糖尿病早期)是否与肿瘤风险增加相关,并寻找糖代谢异常人群中影响肿瘤风险的因素。 方法 2011‐2012年间,来自中国大陆地区25个研究中心的259657名年龄在40岁以上的社区居民被招募参加了REACTION研究的基线调查,并将在第3、5、10年接受随访。每位参与者接受了详细的生活方式问卷调查、体格检查及生化检测,并留取了生物样本,包括血清、尿液和抽提DNA所需的全血标本。 结果 该队列的平均年龄为57 ± 10岁。已诊断和新诊断糖尿病的患者分别占10.32%和10.57%。肿瘤患者总4511例(男性988例,女性3523例),患病率为1.79%。与糖耐量正常的人群相比,校正各类混杂因素后,男性糖尿病患者的胃癌患病比(prevalence ratio,PR)显著降低(PR:0.38,95% CI:0.16–0.89), 女性糖尿病患者所有癌症(PR:1.36,95% CI:1.20–1.56)、乳腺癌(PR:1.56,95% CI:1.21–2.00)、子宫内膜癌(PR:1.58,95% CI:1.16–2.15)、甲状腺癌(PR:1.53,95% CI:1.03–2.27)的患病比显著增加。 结论 多中心的REACTION研究在259657例中国自然人群中收集了大量的有关体格、精神、代谢及健康状况、生化指标及和生活方式信息的数据。
Bibliography:ArticleID:JDB12108
National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology - No. 2012ZX09303006-001
istex:7DAF6AB9A7152BCE2A22597A7C5858E768410700
ark:/67375/WNG-QXG75MXS-7
National High Technology Research and Development Program of China - No. 2011AA020107
National Natural Science Foundation of China - No. 81030011; No. 81222008; No. 81130016
Table S1 Distribution of 25 centers of the REACTION Study (2011-2012), China.
Chinese Society of Endocrinology, the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health - No. 1994DP131044
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1753-0393
1753-0407
DOI:10.1111/1753-0407.12108